China National Medicines Corporation Ltd. (600511.SS) reported a profit for its first quarter that Increased, from the same period last year
The company's earnings totaled RMB474.263 million, or RMB0.6286 per share. This compares with RMB459.015 million, or RMB0.6084 per share, last year.
The company's revenue for the period rose 6.6% to RMB13.555 billion from RMB12.713 billion last year.
China National Medicines Corporation Ltd. earnings at a glance (GAAP) :
-Earnings: RMB474.263 Mln. vs. RMB459.015 Mln. last year.-EPS: RMB0.6286 vs. RMB0.6084 last year.-Revenue: RMB13.555 Bln vs. RMB12.713 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.